7 August 2017 - PHARMAC invites proposals for the supply of a first line enzyme replacement therapy for the treatment of Gaucher disease.

This request for proposals (RFP) letter incorporates the following schedules:

• Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought
  
• Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP
  
• Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceutical
  
• Schedule 4 contains the RFP form in which you are to provide details of your proposal
  

Read PHARMAC Request for Proposal